Renova Related Published Studies
Well-designed clinical trials related to Renova (Tretinoin)
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.09]
A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring. [2008.08]
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.06.28]
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. [2008.04]
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. [2007.07]
Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. [2007.06]
Tretinoin microsphere gel 0.1% for photodamaged facial skin: a placebo-controlled trial. [2006.12]
Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne. [2006.11]
The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. [2005.11]
Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study. [2005.09]
Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. [2005.07]
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%. [2005.04]
Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. [2005]
Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. [2004.12]
Tretinoin treatment before carbon-dioxide laser resurfacing: a clinical and biochemical analysis. [2004.12]
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. [2004.11]
Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study. [2004.06]
Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma. [2004.03]
Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations. [2003.12]
Compared efficacy and safety of tretinoin 0.1% microsphere gel alone and in combination with benzoyl peroxide 6% cleanser for the treatment of acne vulgaris. [2003.08]
Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations. [2003.07]
A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. [2003.01]
A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma. [2002.12.15]
Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial. [2002.09]
Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. [2002.07]
Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. [2002.02]
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. [2001.12]
Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. [2001.10]
Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. [2001.10]
Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies. [2001.08]
Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. [2001.06]
Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel. [2001.02]
A double-blind investigation of the potential systemic absorption of isotretinoin, when combined with chemical sunscreens, following topical application to patients with widespread acne of the face and trunk. [2001.01]
A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China. [2001]
Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. [2001]
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. [2000.12]
A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris. [2000.09]
A comparative evaluation of tretinoin gel microsphere, 0.1%, versus tretinoin cream, 0.025%, in reducing facial shine. [2000.08]
The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. [2000.03]
Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group. [1999.11.01]
Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial. [1999.09]
Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne. [1999]
Effect of topical tretinoin under occlusion on atypical naevi. [1998.12]
Transdermal absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man. [1998.12]
Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne. [1998.11]
Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris. [1998.10]
Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. [1998.10]
Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. [1998.10]
Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne. [1998.07]
Irritation potential of a new topical tretinoin formulation and a commercially-available tretinoin formulation as measured by patch testing in human subjects. [1998.04]
Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris. [1998.04]
Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris. [1998.01]
The use of tretinoin as oral mucositis prophylaxis in bone marrow transplantation patients: a preliminary study. [1997.12]
Sustained improvement in photodamaged skin with reduced tretinoin emollient cream treatment regimen: effect of once-weekly and three-times-weekly applications. [1997.08]
Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. [1997.06]
Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients. [1997.06]
Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments. [1997.06]
Oxyhemoglobin is a quantifiable measure of experimentally induced chronic tretinoin inflammation and accommodation in photodamaged skin. [1997]
Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy. [1996.07]
Topical tretinoin (retinoic acid) improves early stretch marks. [1996.05]
Comparative effect of short-term topical tretinoin and glycolic acid on mechanical properties of photodamaged facial skin in HRT-treated menopausal women. [1996.04]
Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin. [1996.04]
Histologic evaluation of the long term effects of tretinoin on photodamaged skin. [1996.03]
A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. [1996.03]
[Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne] [1996]
Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. [1995.09]
Ultrastructural effects of topical tretinoin on dermo-epidermal junction and papillary dermis in photodamaged skin. A controlled study. [1995.06]
Keratinocyte degeneration in human facial skin: documentation of new ultrastructural markers for photodamage and their improvement during topical tretinoin therapy. [1995.02]
Liposomal tretinoin for uncomplicated acne vulgaris. [1994.12]
Low-dose tretinoin does not improve striae distensae: a double-blind, placebo-controlled study. [1994.08]
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. [1994.06]
Effects of topical tretinoin on dysplastic nevi. [1994.05]
A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. [1994.03]
Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial. [1994.01]
Topical tretinoin improves the appearance of photo damaged skin. [1994]
[Topical tretinoin in the treatment of lichen planus and leukoplakia of the mouth mucosa. A clinical evaluation] [1994]
Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. [1993.10]
Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. [1993.05.20]
Tretinoin emollient cream 0.01% for the treatment of photoaged skin. [1993.01]
Histological evaluation of the effect of 0.05% tretinoin in the treatment of photo damaged skin. Geographic differences in elastosis in baseline biopsies. [1993]
Topical isotretinoin for photodamaged skin. [1992.12]
Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage. [1992.02.06]
Tretinoin emollient cream: a new therapy for photodamaged skin. [1992.02]
Skin replica analysis of photodamaged skin after therapy with tretinoin emollient cream. [1991.08]
Tretinoin accelerates healing after trichloroacetic acid chemical peel. [1991.05]
Effects of tretinoin on photodamaged skin. A histologic study. [1991.05]
Topical tretinoin for treatment of photodamaged skin. A multicenter study. [1991.05]
Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study. [1991.03]
Sustained improvement with prolonged topical tretinoin (retinoic acid) for photoaged skin. [1990.10]
Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. [1990.04]
The effect of topical tretinoin on dysplastic nevi. A preliminary trial. [1990.04]
Clinical effects of long-term therapy with topical tretinoin and cellular mode of action. [1990]
Treatment of photodamaged facial skin with topical tretinoin. [1989.09]
Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial. [1988.04]
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. [1988.01.22]
Well-designed clinical trials possibly related to Renova (Tretinoin)
Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. [2008.09.03]
Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. [2008.08]
Loss of elastic fibers causes skin wrinkles in sun-damaged human skin. [2008.05]
All-trans retinoic acid for treatment of chronic hepatitis C. [2008.03]
Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients. [2008.01]
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. [2007.11.07]
|
